PMID: 9009251Nov 1, 1996Paper

Characterization of newly established human myeloid leukemia cell line (KF-19) and its drug resistant sublines

Leukemia Research
T FukudaT Suzuki

Abstract

A new human myeloid leukemia cell line, designated KF-19, and its drug resistant sublines have been established. The KF-19 cell line was established from the pericardial effusion of a patient with acute myeloid leukemia clinically resistant to chemotherapy and KF-19 cells were characterized by expression of myeloid markers and differentiation into neutrophil- and macrophage-like cells upon optimal stimulations. KF-19AraC, KF-19ADR and KF-19VCR were established as sublines resistant to cytosine arabinoside (AraC), adriamycin (ADR) and vincristine (VCR), respectively. Efflux of the corresponding drugs was documented in each cell line. Expression of the MDR1 gene and the P-glycoprotein was found only in KF-19ADR, which showed a cross resistance to anthracyclines and vinca alkaloids; this resistance was reversed by verapamil or cyclosporin A. KF-19VCR lacking MDR1 gene and P-glycoprotein expression showed only resistance to vinca alkaloids, which was partially reversed by verapamil and cyclosporin A. Unexpectedly, KF-19ADR and KF-19VCR displayed cross resistance to AraC, despite lack of alterations of deoxycytidine kinase (dCK) and deaminase (dA) activities. KF-19AraC showed an efflux of AraC as well as a decreased level of dCK, bu...Continue Reading

References

Jan 18, 1989·Journal of the National Cancer Institute·L J GoldsteinG M Brodeur
Sep 15, 1987·Biochemical Pharmacology·W T Beck
Aug 3, 1988·Biochimica Et Biophysica Acta·G BradleyV Ling
Sep 22, 1971·Nature: New Biology·C D Steuart, P J Burke
Feb 1, 1982·The Journal of Clinical Investigation·J S WileyA R Paterson
Apr 1, 1994·Leukemia Research·K Nooter, P Sonneveld
Dec 1, 1993·Cancer·B Leyland-JonesB I Sikic

❮ Previous
Next ❯

Citations

Apr 27, 2000·Leukemia Research·T FunatoT Sasaki
Jan 10, 2001·Current Opinion in Oncology·T R Chauncey
Jul 9, 2004·Biochemical and Biophysical Research Communications·Christina LöfgrenFreidoun Albertioni

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.